Andexanet alfa in acute aortic syndrome: first UK experience
- PMID: 36943384
- DOI: 10.1093/ejcts/ezad100
Andexanet alfa in acute aortic syndrome: first UK experience
Abstract
Andexanet alfa was employed to reverse the anticoagulant effect of direct oral anticoagulants in 3 patients who required emergent surgery for repair of type A aortic dissection. Its use was instrumental in securing haemostasis. However, we caution against the administration of Andexanet alfa prior to cardiopulmonary bypass as it can induce heparin resistance and complicate the perioperative monitoring of anticoagulation during cardiopulmonary bypass.
Keywords: Acute aortic syndrome; Andexanet alfa; Aorta; Bleeding; Emergency.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
Comment in
-
Andexanet alfa and heparin resistance in cardiac surgery: Experiences and risks associated with the reversal of direct oral anticoagulants.Eur J Cardiothorac Surg. 2023 Jun 1;63(6):ezad189. doi: 10.1093/ejcts/ezad189. Eur J Cardiothorac Surg. 2023. PMID: 37144957 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
